Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGTX
#3947
Cognition Therapeutics, Inc. - Common Stock
1.0
2
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.77%
Monthly Change
+13.33%
6 month change
-4.67%
Year Change
-56.41%
Previous Close
1.0
6
Open
1.0
2
Low
1.0
2
High
1.0
2
Volume
9
Markets
US Stock Market
Healthcare
Biotechnology
CGTX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.08
COGNITION THERAPEUTICS INC quarterly report, Q2 FY2024
10-Q
1
2
3
4
5
News
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain
Cognition Therapeutics, Inc. (CGTX) Q4 2025 Earnings Call Transcript
Cognition presents data on dementia drug zervimesine at conference
Cognition Therapeutics shifts focus to DLB psychosis treatment
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?